OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphoma
Neetha Parameswaran, Liping Luo, Lingjun Zhang, et al.
Leukemia (2023) Vol. 37, Iss. 10, pp. 2050-2057
Open Access | Times Cited: 8
Neetha Parameswaran, Liping Luo, Lingjun Zhang, et al.
Leukemia (2023) Vol. 37, Iss. 10, pp. 2050-2057
Open Access | Times Cited: 8
Showing 8 citing articles:
Ligands of CD6: roles in the pathogenesis and treatment of cancer
Mikel Gurrea‐Rubio, Feng Lin, Max S. Wicha, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Mikel Gurrea‐Rubio, Feng Lin, Max S. Wicha, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
CD6 in Human Disease
Mikel Gurrea‐Rubio, David A. Fox, Javier S. Castresana
Cells (2025) Vol. 14, Iss. 4, pp. 272-272
Open Access
Mikel Gurrea‐Rubio, David A. Fox, Javier S. Castresana
Cells (2025) Vol. 14, Iss. 4, pp. 272-272
Open Access
Applications of Flow Cytometry in Drug Discovery and Translational Research
Sumana Ullas, Charles Sinclair
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3851-3851
Open Access | Times Cited: 2
Sumana Ullas, Charles Sinclair
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3851-3851
Open Access | Times Cited: 2
Expression of CD6 in Aggressive NK/T-cell Neoplasms and Assessment as a Potential Therapeutic Target: A Bone Marrow Pathology Group Study
Xiaoxian Zhao, Chad M. McCall, Jared Block, et al.
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 11, pp. e808-e818
Closed Access | Times Cited: 2
Xiaoxian Zhao, Chad M. McCall, Jared Block, et al.
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 11, pp. e808-e818
Closed Access | Times Cited: 2
Conditional activation of an anti-IgM antibody-drug conjugate for precise B cell lymphoma targeting
Katrin Schoenfeld, Julia Harwardt, Jan Habermann, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Katrin Schoenfeld, Julia Harwardt, Jan Habermann, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
A CD6-targeted antibody-drug conjugate as a potential therapy for T cell–mediated disorders
Lingjun Zhang, Liping Luo, Jin Chen, et al.
JCI Insight (2023) Vol. 8, Iss. 23
Open Access | Times Cited: 4
Lingjun Zhang, Liping Luo, Jin Chen, et al.
JCI Insight (2023) Vol. 8, Iss. 23
Open Access | Times Cited: 4
SexAnnoDB, a knowledgebase of sex-specific regulations from multi-omics data of human cancers
Mengyuan Yang, Yuzhou Feng, Jiajia Liu, et al.
Biology of Sex Differences (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Mengyuan Yang, Yuzhou Feng, Jiajia Liu, et al.
Biology of Sex Differences (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
CD6 and Its Interacting Partners: Newcomers to the Block of Cancer Immunotherapies
Lucía Aragón-Serrano, Laura Carrillo‐Serradell, Violeta Planells-Romeo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17510-17510
Open Access | Times Cited: 3
Lucía Aragón-Serrano, Laura Carrillo‐Serradell, Violeta Planells-Romeo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17510-17510
Open Access | Times Cited: 3
